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Enterococcus faecium, an opportunistic pathogen that causes a significant number of hospital-
acquired infections each year, presents a serious clinical challenge because an increasing
number of infections are resistant to the so-called antibiotic of last resort, vancomycin. Vancomycin
and other new glycopeptide derivatives target the bacterial cell wall, thereby perturbing its
biosynthesis. To help determine the modes of action of glycopeptide antibiotics, we have
developed a bottom-up mass spectrometry approach complemented by solid-state nuclear
magnetic resonance (NMR) to elucidate important structural characteristics of vancomycin-
susceptible E. faecium peptidoglycan. Using accurate-mass measurements and integrating
ion-current chromatographic peaks of digested peptidoglycan, we identified individual
muropeptide species and approximated the relative amount of each. Even though the
organism investigated is susceptible to vancomycin, only 3% of the digested peptidoglycan has
the well-known d-Ala-d-Ala vancomycin-binding site. The data are consistent with a previ-
ously proposed template model of cell-wall biosynthesis where d-Ala-d-Ala stems that are not
cross-linked are cleaved in mature peptidoglycan. Additionally, our mass-spectrometry approach
allowed differentiation and quantification of muropeptide species seen as unresolved chro-
matographic peaks. Our method provides an estimate of the extent of muropeptides contain-
ing O-acetylation, amidation, hydroxylation, and the number of species forming cyclic imides.
The varieties of muropeptides on which the modifications are detected suggest that significant
processing occurs in mature peptidoglycan where several enzymes are active in editing
cell-wall structure. (J Am Soc Mass Spectrom 2008, 19, 1467–1475) © 2008 American Society
for Mass SpectrometryBacterial peptidoglycan is an attractive drug targetbecause it has unique chemistry, and its integrityis crucial to protect cells from internal osmotic
pressure. Vancomycin, a glycopeptide antibiotic target-
ing the peptidoglycan, has become increasingly im-
portant given its effectiveness against multiple drug-
resistant bacteria. Alarmingly, some pathogens have
developed resistance to even vancomycin, the so-called
drug of last resort, leaving clinicians with limited treat-
ment options. Among the most prevalent of these
feared pathogens are vancomycin-resistant enterococci
(VRE).
VRE infections, particularly Enterococcus faecium,
have emerged as life-threatening pathogens in clinical
settings worldwide. Since the first vancomycin-resistant
E. faecium isolate was identified in 1986 [1], the number
Address reprint requests to Professor M. L. Gross, Department of Chemis-
try, Washington University, One Brookings Drive, Campus Box 1134, St.
Louis, MO 63130, USA. E-mail: mgross@wustl.edu
* These two are joint first authors.
© 2008 American Society for Mass Spectrometry. Published by Elsevie
1044-0305/08/$32.00
doi:10.1016/j.jasms.2008.06.020of VRE infections has increased dramatically, causing
high mortality rates around the world. In some hospi-
tals, over 90% of E. faecium isolates are vancomycin
resistant [2]. This presents a significant clinical chal-
lenge and manifests the urgency to find new therapeu-
tic treatment possibilities.
Vancomycin inhibits peptidoglycan biosynthesis of
the bacterial cell wall by forming complexes with the
d-Ala-d-Ala carboxyl termini of peptidoglycan precur-
sors outside the cytoplasmic membrane [3]. Enterococ-
cal resistance is generally thought to involve the mod-
ification of d-Ala-d-Ala binding sites to d-Ala-d-Lac [4].
This change replaces a hydrogen bond between the
nitrogen of the terminal d-Ala and the oxygen of
vancomycin with an oxygen– oxygen repulsive interac-
tion. The modified vancomycin–peptidoglycan stem
complex has an in vitro binding constant over 1000-fold
less than that involving the d-Ala-d-Ala stem [5].
Recently, it was suggested that potent vancomycin-
like glycopeptides, effective against VRE, recognize
other peptidoglycan structural motifs in addition to
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of these new glycopeptide analogues, as well as the
action of vancomycin itself, atomic-level detail of the
enterococcal peptidoglycan is required. To accom-
plish this objective, we have used bottom-up mass spec-
trometry to investigate the structure of vancomycin-
susceptible E. faecium peptidoglycan. In particular, we
are interested in the detailed structure of E. faecium
peptidoglycan, as these structural details may be im-
portant to understanding cell-wall architecture and
drug resistance.
Previously, mass spectrometric interrogations of en-
terococcal peptidoglycan did not address detailed mu-
ropeptide structural variations [8, 9]. Those efforts, as
well as other mass spectrometric analyses of bacterial
peptidoglycan, relied on off-line MS identification
[10–14] of HPLC peaks quantified by ultraviolet absor-
bance [15, 16]. The strategy has proven to be powerful
in characterizing the bacterial cell walls of many differ-
ent organisms [14]. Given the complexity of the biolog-
ical system and difficulty of complete chromatographic
separation, however, each HPLC peak may represent an
indistinguishable mixture of muropeptides, some of
which may not be assigned.
The approach we report here is to use liquid
chromatography–mass spectrometry (LC/MS) coupled
with accurate-mass measurements of digested pepti-
doglycan to identify individual muropeptide species
and, by integrating selected ion-current chromatographic
peaks, estimate the relative amount of each. We verified
the accurate-mass identifications with MS/MS and stable-
isotope labeling experiments. After specifically enriching
amino acids in the peptidoglycan stemwith stable-isotope
labels, we examined unique muropeptide mass shifts to
check our assignments. The sensitivity of our method
allowed us to assign nearly 90% of the peaks in those
mass spectra occurring within the range of expected
muropeptide retention times.
Experimental
Sample Preparation
Starting cultures of E. faecium (ATTC 49624) were pre-
pared by inoculating brain–heart infusion media with a
single colony. Cultures were incubated overnight at
37 °C, but not aerated. Research samples were prepared
by inoculating either brain–heart infusion or sterile
enterococcal standard media (ESM) with the overnight
starter cultures (1% final volume).
ESM was prepared as described before [17]. The pH
of ESM was adjusted to 7.0 before sterile filtration.
Natural abundance amino acids in ESM were replaced
by stable 13C and 15N isotope-enriched amino acids to
incorporate specific labels into the samples for stable-
isotope labeling experiments. All samples enriched with
d-[1-13C]alanine were treated with 5 g/mL of alaphos-
phin, an alanine racemase inhibitor, every 1.5 h ofgrowth to prevent scrambling of the isotopic label from
d-Ala to l-Ala [17].
Cells were harvested at the end of log phase, when
the absorbance at 660 nm became 1.0, by centrifuga-
tion at 10,000  g for 25 min at 4 °C. Pellets were rinsed
with 40 mM triethanolamine hydrochloride (pH 7.0)
three times followed by three rinses with H2O, centri-
fuging after each rinse. Cells were then resuspended in
H2O, frozen, and lyophilized. Cell-wall isolates were
prepared from lyophilized whole cells as detailed be-
fore [18]. The isolated cell walls were digested into
muropeptides with lysozyme and mutanolysin by us-
ing a modified version of the protocol described by
others [1, 8]. All manipulations were performed at
neutral pH.
LC-MS/MS
Liquid chromatography/MS and MS/MS were per-
formed by using a PicoView PV-500 (New Objective,
Woburn, MA) nanospray stage attached to either an
LTQ-FT mass spectrometer or an LTQ-Orbitrap mass
spectrometer (ThermoFisher, San Jose, CA).
Muropeptide samples were loaded into an uncoated
75 um i.d. fused-silica capillary column with a 15 m
picofrit tip (New Objective, Woburn, MA), packed with
C18 reverse-phase material (3 m, 100 Å; Phenomenex,
Torrance, CA). The column was eluted at a flow rate of
250 nL/min for 10 min with 0.1% (vol/vol) formic acid
in water and subsequently with a 60-min linear aceto-
nitrile gradient (0%–40%) with 0.1% formic acid. The
samples, as they emerged from the column, were
sprayed into an LTQ-FT mass spectrometer. Full mass
spectra were recorded in the FT component of the
instrument at 100,000 resolving power (at m/z  400).
Accurate mass product-ion spectra of muropeptides
were acquired by introducing the samples by nanos-
pray as they eluted from the LC to an LTQ-Orbitrap
mass spectrometer. To obtainmajor components’ product-
ion spectra (i.e., species in Scheme 2), cycles consisting
of one full FT-scan mass spectrum and five ensuing
data-dependent MS/MS scans acquired by the Orbitrap
(with a normalized collision energy setting of 35%)
were repeated continuously throughout the elution
with the following dynamic exclusion settings: repeat
count, 3; repeat duration, 15 s; exclusion duration, 30 s.
Sometimes, for minor components, an inclusion list
containing the precursor ions’ masses was applied.
Solid-State NMR
Experiments were performed using a four-frequency
transmission-line probe [19] with a 14-mm long, 9-mm
i.d. analytical coil, and a Chemagnetics/Varian magic-
angle spinning ceramic stator. Lyophilized samples
were spun in Chemagnetics/Varian 7.5-mm o.d. Zirco-
nia rotors at 5.0 kHz under active control within2 Hz.
Experiments were performed at room temperature with
a Chemagnetics CMX-300 spectrometer operating at
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produced by 1-kW Kalmus, ENI, and American Micro-
wave Technology power amplifiers, each under active
control [20];  pulse lengths were 10 s for 15N.
Cross-polarization transfer was at 50 kHz for 2 ms.
Proton dipolar decoupling was at 105 kHz during data
acquisition. The data were taken from a cell-wall sam-
ple with a mass of 150 mg, isolated from a 4 L
preparation.
Results and Discussion
Muropeptide Identification
Enterococcal peptidoglycan-repeat units (see Scheme 1)
are interconnected by cross-linked d-aspartic acid or
d-asparagine (d-Asx) bridges and via the polymeriza-
tion of the disaccharides. We used N-acetylmuramidase
enzymes to catalyze selectively the hydrolysis of the
-1,4 linkages between N-acetylmuramic acid and N-
acetylglucosamine, leaving the cross-links intact. As ex-
pected, on the basis of previous studies [8, 9], most of the
muropeptide peaks in the ion chromatogram (Figure 1)
were variations of monomers, dimers, and a few trimers.
All of the assigned muropeptide species eluted with
a retention time between 15 and 35 min. The mass
spectra, acquired so that accurate masses were taken for
each scan of the ion chromatogram, serve as a means for
evaluating muropeptide contributions. We considered
first accurate-masses that are consistent with traditional
muropeptide structures in a sample prepared with
natural abundance isotopes only (no enrichment).
These structural assignments were confirmed with
MS/MS and stable-isotope labeling experiments. For
example, an ion of m/z 824.4 corresponds to a species
Scheme 1. Representative chemical structure of E. faecium pep-
tidoglycan. The -1,4 linkages between N-acetylmuramic acid and
N-acetylglucosamine are cleaved by N-acetylmuramidase as indi-
cated for the repeat unit on the left. The cross-links remain intact.
d-iso-glutamine and d-aspartic acid may be substituted by either
d-iso-glutamic acid or d-asparagine, respectively.with a tripeptide stem without a bridge (see Scheme 2,
Structure 2). When E. faecium is grown in ESM with
double-labeled aspartic acid, this mass is unaffected.
When the sample is grown with l-[1-13C]lysine and
d-[15N]alanine, the mass of the species increases by that
consistent with the incorporation of one 13C.
Most of the other masses within 15–35 min retention
time could be recognized as a variation of one of the
traditional muropeptide structures. In fact, we were
able to assign components represented by 90% of the
peaks in the mass spectra as muropeptide structures
and verify them by MS/MS and stable-isotope labeling
experiments. It should be emphasized that in the isola-
tion of the muropeptides, the peptidoglycan was not
subjected to any acid or base treatments. Thus, we
associate nearly all of the identified muropeptide struc-
tures as representative of enterococcal peptidoglycan.
Figure 1. Total ion chromatogram for digested E. faecium mu-
ropeptides. The relative intensity is represented by total ion
current as a function of retention time.
Scheme 2. Structures of assigned muropeptides. The relative
proportion of each structure is shown in Table 1.
1470 PATTI ET AL. J Am Soc Mass Spectrom 2008, 19, 1467–1475The few exceptions found were not detected consis-
tently in different sample preparations, and conse-
quently ignored in the analysis.
Structural Quantification
The quantification of each muropeptide species was
estimated using integrals of selected ion chromato-
grams. For species having structural isomers, the inte-
gral was taken as the sum over the entire selected ion
chromatogram. Multiply charged species were also
included in the integrals, and the distributions obtained
by considering multiply charged ions were comparable
to that of singly charged ions. The chromatographic
separation has provided sufficient resolution such that
the overlap of major and minor muropeptide compo-
nents is minimal.
The monomers, dimers, and trimers represent 47%,
43%, and 8% of the muropeptides, respectively. The
identified muropeptide structures (Scheme 2) and their
relative abundances are listed in Table 1. The number of
peptidoglycan stems terminating in d-Ala-d-Ala is only
3%. This quantification is reported as a percentage
normalized to the total number of peptidoglycan stems.
That is, dimer integrals are counted twice and trimer
integrals are counted three times in determining the total
number of peptidoglycan stems. This result is consistent
with that determined in solid-state NMR studies of the
same vancomycin-susceptible E. faecium organism, where
the number of d-Ala-d-Ala terminating stems was found
to be 7% in whole cells [17]. While peptidoglycan
precursors and N-acetylglucosamine-N-acetyl-muramyl-
pentapeptide-pyrophosphoryl-undecaprenol (lipid II)
Table 1. Distribution of structures in E. faecium peptidoglycan
Species Theoretical massa Measure
Monomers
1 695.2856 695.2
2 823.3805 823.3
3 894.4177 894.4
4 938.4075 938.4
5 965.4548 965.4
6 1009.4446 1009.4
7 1080.4817 1080.4
Dimers
8 1814.8151 1814.8
9 1885.8522 1885.8
10 1929.8421 1929.8
11 1956.8894 1956.8
12 2000.8792 2000.8
13 2071.9163 2071.9
Trimers
14 2806.2497 2806.2
15 2921.2767 2921.2
16 2992.3138 2992.3
Tetramers
aTheoretical masses were calculated with Xcalibur 2.0.
bPercentages with respect to monomers, dimers, trimers, and tetrame
cBoth percentages include structural variations of the species (see Table
different sample preparations, each species contribution was within  3% o
dPercentages with respect to total number of peptidoglycan stems.may contribute to the difference in measurements for
the concentration of d-Ala-d-Ala stems, the determina-
tions are still within experimental error (see Validity of
MS Quantification: Comparison with Solid-State NMR Re-
sults section); we are unwilling to attribute any signifi-
cance to the discrepancy.
O-Acetylated Muropeptides
We observed several structural variations of each iden-
tified muropeptide species, one of which is consistent
with O-acetylation of N-acetylmuramic acid corre-
sponding to a mass increase of 42.011 (Figure 2, second
from bottom). O-acetylation of peptidoglycan has been
well studied since it was first reported in 1958 [21, 22].
Thus far, all analyses demonstrate that O-acetylation
only occurs at C6 of N-acetylmuramic acid [23]. The
product-ion spectra (MS/MS) of structures with and
without O-acetylation show the same fragment masses
of N-acetylglucosamine and the peptide stem. On the
other hand, the mass of N-acetylmuramic acid-peptide
stem fragments increases by 42.011 for species with
O-acetylation. These observations provide strong sup-
port for the previous conclusions.
The ester bond of O-linked acetate is sensitive to
mild alkaline hydrolysis [24]. As described above, the
peptidoglycan was isolated at physiological pH, leaving
O-acetylated peptidoglycan intact for MS experiments.
Our results suggest that each muropeptide structure
has a different likelihood of being O-acetylated (Table
2). We estimate that 5–15% of the total peptidoglycan is
O-acetylated on average. The extent of O-acetylation is
significantly lower than the 46-57% that was previously
ss Percentage [%]b,c Percentage [%]c,d
47 30
1 1
22 13
5 3
13 8
1 1
6 4
1 1
43 51
8 10
3 4
23 27
2 2
7 8
1 1
8 15
2 3
5 10
1 2
2 4
nder optimized digestion conditions for data from triplicate runs of fourd ma
855
802
174
071
555
446
825
150
510
420
899
784
158
450
767
140
rs.
2). Uf the values listed here.
with NMR data (see Figure 4).
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species [26–28], the extent of O-acetylation may vary in
different enterococcal strains [25] and may even be
correlated with vancomycin susceptibility in E. faecium.
In digesting the peptidoglycan, we used two N-
acetylmuramidase enzymes, mutanolysin and ly-
sozyme. For many organisms, O-acetylation renders
peptidoglycan resistant to the activity of lysozyme [28],
whereas mutanolysin isolated from Streptomyces glo-
bisporus is not affected by this modification [29]. Indeed,
in the E. faecium preparations digested with only ly-
sozyme, we observed no species with a mass increase
consistent with O-acetylation for any muropeptide
structures. Earlier studies showed large variations be-
tween different enterococcal strains in the lytic response
of their cell walls to lysozyme [30, 31], indicating
different degrees of O-acetylation [32]. Thus, it is not
surprising that the extent of O-acetylation in the strain
of E. faecium we investigated varies from that of a
different strain reported before.
We also observed muropeptide structures that
were N-deacetylated, corresponding to a mass de-
crease of 42.011. The loss of an acetyl residue from N-
acetylglucosamine or N-acetylmuramic acid is infre-
quent in E. faecium, detected in less than 0.2% of the
peptidoglycan stems. We, therefore, ignored these
structures in determining the extent of O-acetylation
as it is highly unlikely that significant numbers of
muropeptides are simultaneously O-acetylated and
N-deacetylated.
Amidation of d-iso-Glu and d-Asp
The occurrence of d-iso-glutamic acid residues in mu-
ropeptide components is hypothesized to affect cross-
linking [33] and vancomycin resistance in Staphylococcus
aureus [34]. Nonamidated peptidoglycan stems may be
inefficient substrates for transpeptidase [35] and have
higher affinity for vancomycin [34], thereby consuming
the antibiotic in the cell wall before it can inhibit
cell-wall biosynthesis at lipid II. E. faecium peptidogly-
can has two potential sites for amidation, d-iso-
glutamine or d-iso-glutamic acid (d-iso-Glx) and d-Asx
(see Scheme 1). Thus, for E. faecium peptidoglycan stems
with bridges, there are three potential ions correspond-
ing to double amidation, amidation/hydroxylation,
and double hydroxylation. Because species with d-iso-
glutamine/d-aspartic acid and d-iso-glutamic acid/
d-asparagine have the same accurate mass, MS identi-
fication of each is difficult. There are, however, rela-
tively few muropeptide structures without bridges that
have a mass corresponding to hydroxylation. The sin-
gly charged muropeptide with an m/z of 824.4 (see
Scheme 2, Structure 2) does not have a bridge and
contains d-iso-glutamine. The peak area for the ion of
m/z 825.4, representing an accurate mass increase of
0.984, corresponding to hydroxylation, is relatively
small compared with that of 824.4 (Figure 3a). This isFigure 2. Mass spectra and assigned structures for variations of
the muropeptide of m/z  939.4150. The most likely structure for
an m/z 939.4150 ion (top) is that with a d-aspartic acid bridge. An
m/z 938.4310 ion (second from top) corresponds to the muropep-
tide with double amidation, d-asparagine and d-iso-glutamine. A
mass increase of 42.011 is consistent with O-acetylation of N-
acetylmuramic acid (second from bottom). A mass decrease of
18.010 suggests the loss of water, and could be indicative of two
types of cyclic imides (bottom). The structure shown is consistentconsistent with there being very few d-iso-glutamic acid-
1472 PATTI ET AL. J Am Soc Mass Spectrom 2008, 19, 1467–1475containing peptidoglycan stems, as was suggested for
other enterococcal organisms [9]. Additionally, it is rare
that muropeptides with bridges have a mass corre-
sponding to double hydroxylation, supporting that few
stems have d-iso-glutamic acid. Thus, we conclude that
most muropeptide species with a mass increase corre-
sponding to a single hydroxylation represent d-iso-
glutamine/d-aspartic acid stems. Approximately 60%
of peptidoglycan bridges are d-aspartic acid, and 2% of
all peptidoglycan stems contain d-iso-glutamic acid
(Table 2).
Structural Bridge Isomers
Selected ion chromatograms of muropeptides with
bridges show two peaks representing components with
different retention times, suggesting that these mu-
ropeptides exist as two structural isomers associated
with unique bridge conformations (Figure 3). The de-
amidation of d-asparagine is known to produce a
mixture of - and -d-aspartic acid residues [36–38].
Recently, however, it was suggested that d-asparagine
bridges in E. faecium exclusively originate from the
amidation of d-aspartic acid after its incorporation into
the peptidoglycan [39]. Further, the incorporation is
thought to proceed specifically by way of a -aspartyl-
phosphate intermediate [40, 41], making - and -
bridge isomers unlikely. Considering that -d-aspartic
acid is incorporated into peptidoglycan precursors, and
that the 1 and 4 aspartyl-carbons are similar, we cannot
Figure 3. Selected ion chromatograms for singly charged species
with m/z of (a) 824.4 and 825.4; (b) 938.4 and 939.4; (c) 1009.5 and
1010.5; and (d) 1080.5 and 1081.5. The relative intensities of 1080.5
and 1081.5 are small, consistent with there being few d-Ala-d-Ala
stems. Muropeptides with bridges elute as two distinct peaks with
different retention times in the chromatogram. The selected ion
Table 2. Distribution of selected monomers
Species Acetylation [%] Cyclic Imide [%]
2 19
3 2
4 11 8
5 4 3
6 3 2chromatogram for m/z 824.4 shows only one peak.rule out the possibility that either carbon could form a
peptide bond with the 6-N-lysine, thereby creating two
unique bridge conformations.
Cyclic Imides
Interestingly, the muropeptide monomers we assigned
to have aspartic acid bridges show a relatively small
amount of species with an accurate mass decrease of
18.010 consistent with the loss of water (Figure 2,
bottom). MS/MS experiments indicate that the water
loss is not from the disaccharides or the first amino acid
of the peptide stem, l-alanine. Moreover, tripeptide
monomers with bridges (see Scheme 2, Structure 4) also
undergo water loss before mass spectrometry analysis.
We hypothesize that the water loss results in the
formation of a cyclic imide structure for which there are
at least two possibilities. Aspartic acid could form a
succinimide with 6-N-lysine (see Figure 2, bottom) or
undergo cyclization with N-d-iso-glutamine.
Using the current mass spectrometric data, we are
unable to differentiate between the two proposed vari-
eties of cyclic imides. Monomeric muropeptides con-
taining d-iso-glutamine and d-asparagine do not show
mass decreases consistent with water loss, probably
because there is no free hydroxyl to be protonated and
become a leaving group. If water loss were to occur
from stems containing both d-iso-glutamic acid and
d-aspartic acid, it would suggest that the succinimide is
the favored structure. Unfortunately, the infrequency of
d-iso-glutamic acid containing muropeptide stems
makes this analysis difficult. It should be noted that
some structures with a missing water molecule, such as
that with an m/z of 939.4, produce two peaks with
different retention times in the ion chromatogram. This
may be representative of both types of cyclic imide
structures or a consequence of there being two bridge
orientations as discussed above.
Solid-state NMR experiments performed on intact
cell-wall isolates specifically labeled with l-[6-15N]l-
ysine provide insight in the identification. An 15N
cross-polarization magic-angle spinning (CPMAS) echo
spectrum is consistent with a succinimide structure
(Figure 4). The peak at 5 ppm is due to lysyl amines and
the peak at 95 ppm is for lysyl amides. We suggest that
the small peak at 151 ppm is from lysyl succinimides,
representing a small percentage of peptidoglycan
ln/Asn [%] Gln/Asp (Glu/Asn) [%] Glu/Asp [%]
41 58 1
16 83 1
23 75 2Gbridges. Although succinimides were proposed as in-
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detection of such structures in E. faecium peptidoglycan.
Muropeptides Without Asx Bridges
The solid-state NMR 15N CPMAS echo spectrum of E.
faecium cell-wall isolates shows, from the ratio of the
amine to amide peak, that a significant percentage of
peptidoglycan stems do not have bridges [17]. This
result contrasts with those from previous mass spectro-
metric studies in which it was concluded that over 95%
of the enterococcal peptidoglycan contains bridges [8].
Results from our MS experiments are consistent with
solid-state NMR data, showing nearly 30% of pepti-
doglycan stems do not have bridges. The significant
number of muropeptide stems without bridges is
shown by the relative intensity of m/z 824.4 (amidated
species 2 of Scheme 2) compared with other species (see
Figure 3). The discrepancy in bridge-links between our
data and those given in previous MS studies may be
related to the specific strain of E. faecium investigated, or
it may result from excessive mutanolysin digestion of
muropeptides. The cell walls we digested with only
lysozyme showed significant proportions of lysyl amine
structures, but no structures consistent with O-acetyla-
tion. In cell walls digested with high concentrations of
mutanolysin and lysozyme for 24 h, lysyl amine mu-
ropeptides decreased, representing less than 5% of the
peptidoglycan. Additionally, the ion chromatogram
profile changed. For example, the ratio of structures
with an m/z of 824.4 to that of 825.4 (hydroxylated
species 2 of Scheme 2) changed by a factor of six times,
Figure 4. 15N CPMAS echo-spectrum of E. faecium cell-wall
isolates enriched with l-[6-15N]lysine. The amide peak at 95 ppm
occurs when lysine has a d-Asx bridge attached, and the amine
peak at 5 ppm occurs when lysine does not have an attached
bridge. We assign the 151 ppm peak to lysyl succinimides.indicating that high concentrations of mutanolysin mayfurther degrade some muropeptides after having
cleaved the -1,4 glycan linkages. To optimize the
digestion, the concentration and digestion times were
reduced such that the treatment produced significant
proportions of lysyl amine muropeptides consistent
with solid-state NMR measurements made on cell-wall
isolates before digestion while still solubilizing a sub-
stantial amount of peptidoglycan and cleaving
O-acetyl-substituted oligomers.
Validity of MS Quantification: Comparison with
Solid-State NMR Results
The MS quantifications in this report are based on
integrals obtained from ion chromatograms, and given
that there are likely to be differences in ionization
efficiencies between muropeptide structures and poten-
tial digestion sampling problems, we view them as
approximations. Nonetheless, the investigation has re-
vealed several new structural details of E. faecium
peptidoglycan, the relative proportion of each motif,
and the types of stems on which they occur. As a
method to judge the quantitative integrity of the MS
results, the percentage of total peptidoglycan stems
cross-linked can be calculated and compared with that
directly measured by solid-state NMR. Cross-linking is
equal to: (dimers  2 · trimer  3 · tetramers)/(mono-
mers  2 · dimers  3 · trimers  4 · tetramers). From
the MS data, 40% of E. faecium peptidoglycan is
cross-linked. This result is in good agreement with the
47% obtained from solid-state NMR [17].
Glycan Chain Lengths
The absence of cross-linked chains longer than tetra-
mers contrasts with the peptidoglycan from Staphylo-
coccus aureus, another gram-positive pathogen, where
cross-linked chains greater than 9-mers were observed
after N-acetylmuramidase digestion [42]. In comparison
to S. aureus, we propose that E. faecium compensates for
the lack of peptidoglycan integrity resulting from short
cross-linked fragments by extending the length of the
glycan chains. No data have been reported for E. faecium
glycan chain length, but we anticipate that it will be
much longer than in S. aureus, where the average was
reported to be six disaccharides [43]. Average glycan
lengths as long as 140 disaccharides have been reported
in some B. subtilis species [44].
Template Model for Cell-Wall Biosynthesis
Both MS and solid-state NMR results show that the
number of peptidoglycan stems terminating in d-Ala-
d-Ala is small despite this organism’s susceptibility
to vancomycin. Nevertheless, these binding sites are
crucial to cell-wall biosynthesis, and their small num-
ber is fundamentally consistent with the template
model proposed for S. aureus [6, 7] and recently
yclic
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In this single-strand addition model, the orientation of
nascent peptidoglycan is signaled by the stem confor-
mation of the template, the last completed glycan chain
(Figure 5). For the template to form cross-links with the
extending nascent peptidoglycan, it must have d-Ala-d-
Ala stems. These few stems represent the 3% of all
d-Ala-d-Ala peptidoglycan observed in MS experiments.
Modification of the few d-Ala-d-Ala stems in nascent and
template peptidoglycan prevents the binding of vancomy-
cin and its ensuing inhibition of the enzymatic processes
crucial for cell-wall assembly. We suspect that there is an
active l,d-carboxypeptidase that cleaves d-Ala-d-Ala
stems that are not cross-linked inmature peptidoglycan. It
was suggested that l,d-carboxypeptidase activity is in-
volved in peptidoglycan maturation for other organisms
[45–48]. In addition to l,d-carboxypeptidase activity, we
propose that other enzymatic modifications also occur
in mature peptidoglycan. Examples include O-acetyla-
tion, amidation of aspartic acid, and formation of cyclic
imides, which occur less frequently on muropeptides
associated with nascent and template peptidoglycan,
namely those with d-Ala-d-Ala stems (see Table 2). The
Figure 5. Two-dimensional schematic repres
biosynthesis for E. faecium. Chain extension o
cross-linking at lipid II. The few peptidoglyca
nascent and template peptidoglycan where they
acts on stems in mature peptidoglycan that ar
editing enzymatic processes occur in mature p
O-acetylation (green), d-asparagine (blue), and cresults suggest that significant processing occurs inmature peptidoglycan where several enzymes are ac-
tive in editing cell-wall structure. Modified mature
peptidoglycan may play an important role in biosyn-
thetic regulation and prove important in virulence,
allowing bacterial infections to evade host-immune
system response.
Conclusions
Mass spectrometry, particularly in LC/MS mode in
which accurate masses and product-ion spectra are
acquired, can provide new structural detail pertaining
to variations of peptidoglycan stems. These results
may prove important in understanding glycopeptide-
antibiotic binding. One source of success of our bottom-up
approach is the gentle treatments for digestion under
neutral pH that allow the fine structure of the pepti-
doglycan to be preserved. Using this gentle digestion,
we implemented an on-line LC/MS analysis that gives
results suitable for comparison with those from solid-
state NMR, a method with excellent quantitative sensi-
tivity and reliability. The comparison verifies that,
despite being susceptible to vancomycin, vancomycin-
ion of the template model of peptidoglycan
from right to left and is synchronized with
ms terminating in d-Ala-d-Ala (red) occur in
ross-linked. We suspect that l,d-carboxypeptidase
cross linked. We propose that other cell-wall
oglycan as well, creating muropeptides with
imides (purple).entat
ccurs
n ste
are c
e not
eptidsusceptible Enterococcus faecium have very few d-Ala-d-
1475J Am Soc Mass Spectrom 2008, 19, 1467–1475 PEPTIDOGLYCAN STRUCTURE OF VSEAla binding sites. The finding is consistent with a
template model for cell-wall biosynthesis and suggests
that l,d-carboxypeptidase activity exists in E. faecium
peptidoglycan. The importance of infrequently occur-
ring peptidoglycan structural motifs, such as the bind-
ing site of vancomycin, underscores the need for char-
acterizing fine peptidoglycan structural details, as was
accomplished by this research.
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